Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation

[1]  Balachandran Manavalan,et al.  Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework , 2022, iScience.

[2]  L. Zhuangzhuang,et al.  Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. , 2022, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[3]  M. Mercola,et al.  Repurposing drugs to treat cardiovascular disease in the era of precision medicine , 2022, Nature Reviews Cardiology.

[4]  Ke Liu,et al.  Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  L. Teng,et al.  The Neuroprotection of Verbascoside in Alzheimer’s Disease Mediated through Mitigation of Neuroinflammation via Blocking NF-κB-p65 Signaling , 2022, Nutrients.

[6]  Lisheng Wang,et al.  Identification of Active Ingredients of Huangqi Guizhi Wuwu Decoction for Promoting Nerve Function Recovery After Ischemic Stroke Using HT22 Live-Cell-Based Affinity Chromatography Combined with HPLC-MS/MS , 2021, Drug design, development and therapy.

[7]  Linsheng Liu,et al.  Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects , 2021, Frontiers in Pharmacology.

[8]  A. Orekhov,et al.  BaZiBuShen alleviates cognitive deficits and regulates Sirt6/NRF2/HO-1 and Sirt6/P53-PGC-1α-TERT signaling pathways in aging mice. , 2021, Journal of ethnopharmacology.

[9]  Jihong Han,et al.  The therapeutic effect and mechanism of Qishen Yiqi dripping pills on cardiovascular and cerebrovascular diseases and diabetic complications. , 2021, Current Molecular Pharmacology.

[10]  B. Hyman,et al.  Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease , 2021, Neuropathology and applied neurobiology.

[11]  Linsheng Liu,et al.  Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects , 2021, Frontiers in Pharmacology.

[12]  A. Orekhov,et al.  BaZiBuShen alleviates altered testicular morphology and spermatogenesis and modulates Sirt6/P53 and Sirt6/NF-κB pathways in aging mice induced by D-galactose and NaNO2. , 2021, Journal of ethnopharmacology.

[13]  Xiang Xie,et al.  Homotherapy for heteropathy active components and mechanisms of Qiang-Huo-Sheng-Shi decoction for treatment of rheumatoid arthritis and osteoarthritis , 2020, Comput. Biol. Chem..

[14]  Yue-Ming Li,et al.  Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. , 2020, RSC medicinal chemistry.

[15]  G. Salvesen,et al.  Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion , 2020, Nature Communications.

[16]  Cong Wei,et al.  Chinese medicine Bazi Bushen capsule improves lipid metabolism in ovariectomized female ApoE-/- mice. , 2020, Annals of palliative medicine.

[17]  Jia Sun,et al.  Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models , 2020, Scientific Reports.

[18]  A. Shekhar,et al.  Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs , 2019, Molecular Psychiatry.

[19]  Feng Zhu,et al.  Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics , 2019, Nucleic Acids Res..

[20]  T. Ozben,et al.  Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease. , 2019, Clinical biochemistry.

[21]  Y. Chin,et al.  Drug repurposing in alternative medicine: herbal digestive Sochehwan exerts multifaceted effects against metabolic syndrome , 2019, Scientific Reports.

[22]  H. Okano,et al.  Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations , 2019, Molecular Brain.

[23]  Andrew R. Leach,et al.  Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery , 2019, Journal of Cheminformatics.

[24]  Michelle Giglio,et al.  Human Disease Ontology 2018 update: classification, content and workflow expansion , 2018, Nucleic Acids Res..

[25]  Yan Li,et al.  Network Pharmacology to Unveil the Biological Basis of Health-Strengthening Herbal Medicine in Cancer Treatment , 2018, Cancers.

[26]  Evan Bolton,et al.  PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..

[27]  Wei Zhang,et al.  ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..

[28]  Shiwen Zhao,et al.  Network-based drug repositioning: A novel strategy for discovering potential antidepressants and their mode of action , 2018, European Neuropsychopharmacology.

[29]  D. Zhu,et al.  nNOS–CAPON interaction mediates amyloid‐β‐induced neurotoxicity, especially in the early stages , 2018, Aging cell.

[30]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[31]  Yan Shi,et al.  TCMID 2.0: a comprehensive resource for TCM , 2017, Nucleic Acids Res..

[32]  T. Misteli,et al.  Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases , 2017, Nature Reviews Molecular Cell Biology.

[33]  Kang Ning,et al.  TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations , 2017, Scientific Reports.

[34]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[35]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[36]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[37]  Jie Dong,et al.  TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models , 2016, Journal of Computer-Aided Molecular Design.

[38]  Li Zhou,et al.  [Determination of 14 components in Bazibushen capsule by UPLC-ESI-MS/MS]. , 2016, Yao xue xue bao = Acta pharmaceutica Sinica.

[39]  Yong Wang,et al.  BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine , 2016, Scientific Reports.

[40]  K. Søreide,et al.  Molecular and biological hallmarks of ageing , 2016, The British journal of surgery.

[41]  Damian Szklarczyk,et al.  STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..

[42]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[43]  Sang-Kyun Kim,et al.  TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine , 2015, BMC Complementary and Alternative Medicine.

[44]  Aurélien Grosdidier,et al.  SwissTargetPrediction: a web server for target prediction of bioactive small molecules , 2014, Nucleic Acids Res..

[45]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[46]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[47]  Bo Zhang,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application: Traditional Chinese medicine network pharmacology: theory, methodology and application , 2014 .

[48]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[49]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[50]  Shiwen Zhao,et al.  A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..

[51]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[52]  Shiwen Zhao,et al.  Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification , 2010, PloS one.

[53]  G. Superti-Furga,et al.  Target profiling of small molecules by chemical proteomics. , 2009, Nature chemical biology.

[54]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[55]  Hsin-Hsi Chen,et al.  TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining , 2008, BMC complementary and alternative medicine.

[56]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[57]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[58]  E. Sinforiani,et al.  Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease , 2006, Neurology.

[59]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[60]  Shumei Wang,et al.  LC-high-resolution-MS/MS analysis of chemical compounds in rat plasma after oral administration of Nao-Mai-Tong and its individual herbs. , 2017, Biomedical chromatography : BMC.

[61]  A. Hopkins.  Network pharmacology , 2007, Nature Biotechnology.